Batavia Biosciences, a leading contract development and manufacturing organization, is expanding its partnership with ...

The collaboration arrives at a critical moment when pharmaceutical companies are racing to adopt AI but wrestle with unprecedented volumes of complex scientific data, much of it locked in proprietary ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal ...

VOV.VN - The Vietnam Vaccine Joint Stock Company (VNVC) has officially signed a contract with the Rieckermann Group (Germany) ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc.

VisiRose Inc. (”VisiRose” or the “Company”), a privately-held, clinical-stage biotechnology company developing novel ocular ...

Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...

The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...

Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...